Abstract:Glaucoma, a chronic and multifactorial neurodegenerative disease, is the leading cause of irreversible blindness. It is characterized by the degeneration of retinal ganglion cells (RGCs), loss of their axons, and damage to the lamina cribrosa. To study glaucomatous optic neuropathy, experimental rodent models are commonly used due to their low cost, ease of handling, and similarities to the human retina. The ideal model must reproduce tissue changes observed in human glaucoma, such as alterations of the optic nerve head, thinning of the retinal nerve fibre layer, activation of glial cells, and progressive degeneration of RGCs. The DBA/2J transgenic mouse model is the most commonly used genetic model, characterized by a gradual increase in intraocular pressure (IOP) with age, leading to rapid and progressive loss of RGCs and optic nerve degeneration. However, limitations such as iris atrophy and peripheral anterior synechiae can alter the anterior segment and influence IOP measurement. Induced models of ocular hypertension (OHT) have a predictable IOP increase following experimental procedures, but this increase is usually rapid and sustained for a relatively short time, which may not represent the slow and sustained IOP elevation observed in primary open‐angle glaucoma. Nonetheless, induced models produce similar pathophysiological mechanisms to genetic models. Other models include the injection of hypertonic saline into episcleral veins to cause scarring of the trabecular meshwork and elevate IOP, and the intracameral injection of polystyrene or magnetic microbeads to obstruct normal drainage flow of aqueous humour, resulting in an IOP increase. A new model employs an intracameral injection of a cross‐linking polymer that produces a viscosity increase, impeding normal drainage of the aqueous humour and resulting in an IOP increase and loss of RGCs. In this SIS, we review the different glaucoma models, their methods, and the retinal tissue changes, with a focus on microglial cell changes.

Silicone Oil-Induced Ocular Hypertension Glaucoma Model (SOHU) in Rodent and Nonhuman Primate.

Chronic mild and acute severe glaucomatous neurodegeneration derived from silicone oil-induced ocular hypertension

Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse

Silicone Oil-Induced Glaucomatous Neurodegeneration in Rhesus Macaques

In Situ-Crosslinked Hydrogel-Induced Experimental Glaucoma Model with Persistent Ocular Hypertension and Neurodegeneration.

Relevant Variations and Neuroprotecive Effect of Hydrogen Sulfide in a Rat Glaucoma Model

Silicone oil induced glaucoma: A review

IOP Reduction in Nonhuman Primates by Microneedle Injection of Drug-Free Hydrogel to Expand the Suprachoroidal Space

Microbead-Induced Ocular Hypertensive Mouse Model For Screening And Testing Of Aqueous Production Suppressants For Glaucoma

Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma.

Microglial involvement in ocular hypertension

Intraocular Pressure Rise Linked to Silicone Oil in Retinal Surgery: A Review

Long-term effect on optic nerve of silicone oil tamponade in rabbits: histological and EDXA findings

Mouse model of ocular hypertension with retinal ganglion cell degeneration

The Effect of A2AReceptor Antagonist on Microglial Activation in Experimental Glaucoma

Surgical Treatment in Silicone Oil-Associated Glaucoma

In Vivo Models of Steroid-Induced Intraocular Hypertension

Silicone oil as a corneal lubricant to reduce corneal edema and improve visualization during vitrectomy

An inducible rodent glaucoma model that exhibits gradual sustained increase in intraocular pressure with distinct inner retina and optic nerve inflammation

Endogenous dual stimuli-activated NO generation in the conventional outflow pathway for precision glaucoma therapy.

Intraocular pressure changes during and after silicone oil endotamponade (Review)